The role of FGF-2 in smoke-induced emphysema and the therapeutic potential of recombinant FGF-2 in patients with COPD |
Kim, You-Sun
(Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Hong, Goohyeon (Department of Internal Medicine, Dankook University College of Medicine) Kim, Doh Hyung (Department of Internal Medicine, Dankook University College of Medicine) Kim, Young Min (Department of Internal Medicine, Dankook University College of Medicine) Kim, Yoon-Keun (Institute of MD Healthcare, Inc) Oh, Yeon-Mok (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) Jee, Young-Koo (Department of Internal Medicine, Dankook University College of Medicine) |
1 | Pardo, O. E. et al. Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. J. Biol. Chem. 277, 12040-12046 (2002). DOI |
2 | Pardo, O. E. et al. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol. Cell Biol. 23, 7600-7610 (2003). DOI |
3 | Aubry, M. C.,Wright, J. L. &Myers, J. L. The pathology of smoking related lung diseases. Clin. Chest Med. 21, 11-35 (2000). vii. DOI |
4 | Sun, C. et al. LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease. Lab. Invest. 94, 991-1002 (2014). DOI |
5 | Kim, S. H. et al. Perceptions of severe asthma and asthma-COPD overlap syndrome among specialists: a questionnaire survey. Allergy Asthma Immunol. Res. 10, 225-235 (2018). DOI |
6 | Krimmer, D. I., Burgess, J. K., Wooi, T. K., Black, J. L. & Oliver, B. G.Matrix proteins from smoke-exposed fibroblasts are pro-proliferative. Am. J. Respir. Cell Mol. Biol. 46, 34-39 (2012). DOI |
7 | Hogg, J. C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653 (2004). DOI |
8 | James, A. L. & Wenzel, S. Clinical relevance of airway remodelling in airway diseases. Eur. Respir. J. 30, 134-155 (2007). DOI |
9 | Turner, N. & Grose, R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116-129 (2010). DOI |
10 | Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018. Available at: http://www.goldcopd.org/. |
11 | Wedzicha, J. A. et al. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N. Engl. J. Med 374, 2222-2234 (2016). DOI |
12 | Janson, C. et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting 2 agonist: observational matched cohort study (PATHOS). BMJ 346, f3306 (2013). DOI |
13 | Morse,D. & Rosas, I. O. Tobacco smoke-induced lung fibrosis and emphysema. Annu Rev. Physiol. 76, 493-513 (2014). DOI |
14 | Talikka, M. et al. Genomic impact of cigarette smoke, with application to three smoking-related diseases. Crit. Rev. Toxicol. 42, 877-889 (2012). DOI |
15 | MacNee, W. Oxidants/antioxidants and COPD. Chest 117(5Suppl 1), 303S-317SS (2000). |
16 | Celedon, J. C. et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum. Mol. Genet 13, 1649-1656 (2004). DOI |
17 | Chen, P. Y. et al. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF)-dependent smooth muscle cell phenotype modulation. Sci. Rep. 6, 33407 (2016). DOI |
18 | Nugent, M. A. & Iozzo, R. V. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32, 115-120 (2000). DOI |
19 | Lee, B. J. et al. Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-. Exp. Mol. Med. 43, 169-178 (2011). DOI |
20 | Bikfalvi, A., Klein, S., Pintucci, G. & Rifkin, D. B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18, 26-45 (1997). |
21 | Shute, J. K. et al. Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax 59, 557-562 (2004). DOI |
22 | Burgess, J. K. The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacol. Ther. 122, 19-29 (2009). DOI |
23 | Hoshino, M., Takahashi, M. & Aoike, N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J. Allergy Clin. Immunol. 107, 295-301 (2001). DOI |
24 | Redington, A. E. et al. Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J. Allergy Clin. Immunol. 107, 384-387 (2001). DOI |
25 | Kawago, M. et al. Intrapleural administration of gelatin-embedded, sustainedrelease basic fibroblast growth factor for the regeneration of emphysematous lungs in rats. J. Thorac. Cardiovasc. Surg. 147, 1644-1649 (2014). DOI |
26 | Chang, S. S., Yokomise, H., Matsuura, N., Gotoh, M. & Tabata, Y. Novel therapeutic approach for pulmonary emphysema using gelatin microspheres releasing basic fibroblast growth factor in a canine model. Surg. Today 44, 1536-1541 (2014). DOI |
27 | Morino, S. et al. Fibroblast growth factor-2 promotes recovery of pulmonary function in a canine models of elastase-induced emphysema. Exp. Lung Res. 33, 15-26 (2007). DOI |
28 | Morino, S. et al. Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models. Chest 128, 920-926 (2005). DOI |
29 | Jeon, S. G. et al. Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J. Allergy Clin. Immunol. 119, 831-837 (2007). DOI |
30 | Kim, Y. S. et al. The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: a pilot study. Allergy Asthma Respir. Dis. 2, 200-207 (2014). DOI |
31 | Schaper, W., De Brabander, M. & Lewi, P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ. Res. 28, 671-679 (1971). DOI |
32 | Huh, J. W. et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L255-L266 (2011). DOI |
33 | Kim, Y. S. et al. Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses. Clin. Exp. Allergy 43, 443-454 (2013). DOI |
34 | Lazarous, D. F. et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145-153 (1995). DOI |
35 | Partridge, M. R. et al. Development and validation of the capacity of daily living during the morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur. Respir. J. 36, 96-104 (2010). DOI |
36 | Lommatzsch, M. et al. Acute effects of tobacco smoke on human airway dendritic cells in vivo. Eur. Respir. J. 35, 1130-1136 (2010). DOI |
37 | Costabel, U. & Guzman, J. Effect of smoking on bronchoalveolar lavage constituents. Eur. Respir. J. 5, 776-779 (1992). |
38 | Kuschner, W. G., D'Alessandro, A., Wong, H. & Blanc, P. D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur. Respir. J. 9, 1989-1994 (1996). DOI |
39 | Burke, W. M. et al. Smoking-induced changes in epithelial lining fluid volume, cell density and protein. Eur. Respir. J. 5, 780-784 (1992). |